Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 1-2 , April 2010

Leveraging clinical performance by technological excellence – The case of particle therapy

  • Dag Rune Olsen

      Affiliations

    • Faculty of Mathematics and Natural Sciences, University of Bergen, Norway
    • ,
  • Jens Overgaard

      Affiliations

    • Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    • Corresponding Author InformationCorresponding author. Address: Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, Bld. 5, DK-8000 Aarhus C, Denmark.

References 

  1. Brenner DJ, Hall EJ. Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiother Oncol. 2008;86:165–170
  2. Thorwarth D, Soukup M, Dose AlberM. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. Radiother Oncol. 2008;86:30–34
  3. Albertini F, Bolsi A, Lomax AJ, Rutz HP, Timmerman B, Goitein G. Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol. 2008;86:187–194
  4. Georg D, Hillbrand M, Stock M, Dieckmann K, Pötter R. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol. 2008;88:368–375
  5. Hillbrand M, Georg D, Gadner H, Pötter R, Dieckmann K. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol. 2008;89:141–149
  6. Schneider U, Lomax A, Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol. 2008;89:135–140
  7. Moon SH, Shin KH, Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol. 2009;90:66–73
  8. Vernimmen FJ, Mohamed Z, Slabbert JP, Wilson J. Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas. Radiother Oncol. 2009;90:208–212
  9. Bouchard M, Amos RA, Briere TM, Beddar S, Crane CH. Dose escalation with proton or photon radiation treatment for pancreatic cancer. Radiother Oncol. 2009;92:238–243
  10. Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation therapy of cancer patients. Radiother Oncol. 2010;95:3–22
  11. Glimelius B, Ask A, Bjelkengren G, et al. For the Swedish proton therapy centre project. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44:257–271
  12. Olsen DR, Bruland ØS, Frykholm G, et al. Proton therapy: a systematic review of clinical effectiveness. Radiother Oncol. 2007;83:123–132
  13. Lodge M, Pijls-Johannesma M, Stirk L, et al. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol. 2007;83:110–122
  14. Widesott L, Amichetti M, Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol. 2008;86:154–164
  15. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue?. Radiother Oncol. 2008;86:142–147
  16. Suit H, Kooy H, Trofimov A, et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol. 2008;86:148–153
  17. Goitein M. Trials and tribulations in charged particle radiotherapy. Radiother Oncol. 2010;95:23–31
  18. Wilkens JJ, Oelfke U. Direct comparison of biologically optimized spread-out Bragg peaks for protons and carbon ions. Radiother Oncol. 2008;70:262–266
  19. Hofmann B. Fallacies in the arguments for new technology: the case of proton therapy. J Med Ethics. 2009;35:684–687
  20. Combs SE, Jäkel O, Haberer T, Debus J. Particle therapy at the Heidelberg Ion Therapy Center (HIT) – integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol. 2010;95:41–44
  21. Combs SE, Hartmann C, Nikoghosyan A, et al. Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol. 2010;95:54–59
  22. Holzscheiter MH, Bassler N, Agazaryan N, et al. The biological effectiveness of antiproton irradiation. Radiother Oncol. 2006;81:233–242
  23. Bassler N, Alsner J, Beyer G, et al. Antiproton radiotherapy. Radiother Oncol. 2008;86:14–19
  24. Paganetti H, Goitein M, Parodi K. Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy. Radiother Oncol. 2010;95:79–86
  25. Bassler N, Kantemiris I, Karaiskos P, Engelke J, Holzscheiter MH, Petersen JB. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams. Radiother Oncol. 2010;95:87–93
  26. Pijls-Johannesma M, Pommier P, Lievens Y. Cost-effectiveness of particle therapy: current evidence and future needs. Radiother Oncol. 2008;89:127–134

PII: S0167-8140(10)00181-7

doi: 10.1016/j.radonc.2010.03.018

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 1-2 , April 2010

Article Tools